Early assessment of antibodies decline in Chagas patients following treatment using a serological multiplex immunoassay
InfectologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Nature communications
- Publicado em
- 3 dez 2024
- Citações
- 9
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Early assessment of antibodies decline in Chagas patients following treatment using a serological multiplex immunoassay
Ursula Saade, Jasper de Boer, Ivan Scandale, Jaime Altcheh, Hans Pottel, Eric Chatelain, Maan Zrein
Descritores MeSH
- Antibodies, Protozoan
- Trypanocidal Agents
- Trypanosoma cruzi
- Chagas Disease
- Nitroimidazoles
- Male
- Middle Aged
- Nifurtimox
- Retrospective Studies
- Adult
Veja também
Estudos relacionados
- Mechanisms of resistance of Trypanosoma cruzi to benznidazole and nifurtimox: Molecular implications and multifaceted impact
- Prevention of congenital chagas disease by trypanocide treatment in women of reproductive age: A meta-analysis of observational studies
- Value of the Run-In Period to Evaluate the Safety of Conventional Trypanocidal Treatment: A Subanalysis of a Colombian Randomized Clinical Trial
- Cutaneous reactions during treatment with Nifurtimox or Benznidazole among Trypanosoma cruzi seropositive adults without symptomatic cardiomyopathy: A safety sub analysis of a placebo-controlled randomised trial